James Kimmel, Jr., is a lecturer of psychiatry at the Yale School of Medicine, a lawyer, and the founder and co-director of the Yale Collaborative for Motive Control Studies. He is the creator of The ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

Live from WYFF 4 studios, Chronicle: State of Addiction was a community event that featured law enforcement and addiction specialists answering viewer questions and discussing issues and solutions ...

Washington — President Trump signed an executive order Thursday evening to coordinate a federal government response to drug addiction and substance abuse. According to a White House fact sheet, the ...

First-person stories of drug addiction, hope, healing, and recovery. Addiction is a complex and often misunderstood condition. This gripping special provides raw, unfiltered access to first-person ...

As the nation’s director of drug control policy, James Carroll says “one thing is clear” when it comes to dealing with what he describes as the nation’s “unprecedented crisis” of drug addiction.

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) ...